Innovations in Care...
...Improvements in
Lives
...Improvements in
Lives...Improvements in
Lives 
Home • About Us •
Gamma Detection Devices
• Blood
Flow Measurement • Investigational
Initiatives • News
& Investors • Contact
Us • Site
Map
|
|
|||
 |
|
|
||
 |
|
|||
| Investor Relations Neoprobe's stock price, annual report, and press releases are all available for your review by clicking on the applicable icon at the left. General information inquiries or to request an investor relations packet be sent to you, please call Neoprobe at 1-614-793-7500 ext. 188 or contact us by e-mail at info@neoprobe.com. Specific questions or inquiries should be directed to the following individuals: Correspondence by mail should be sent to: 425 Metro Place North, Suite 300 Dublin, OH 43017 Contact by telephone may be made by dialing: Toll-free (U.S.): 800-793-0079 Tel: 614-793-7500 Fax: 614-793-7520 President and CEO David C. Bupp, ext. 132 Vice President, Finance & CFO Brent L. Larson, ext. 133 E-mail regarding investor relations inquiries may be directed to: info@neoprobe.com You are also encouraged to contact Neoprobe’s investor relations representatives at the following address: The Trout Group Tim Ryan, Tel: (212) 477 9007 , ext. 24 www.troutgroup.com |
|
|||
| |
||||
| Copyright © Neoprobe Corporation. All rights reserved. Your use of the information on this site is subject to our terms of use. | |
|||
